IP Library Granted Patent US 11,420,972
Granted Patent B2
US 11,420,972 · App. 16/879,491 · Granted Aug 23, 2022

Methods and compounds for treating

Inventors: Richard L. Mackman (Millbrae, CA); Jay P. Parrish (Redwood City, CA); Adrian S. Ray (Redwood City, CA); Dorothy Agnes Theodore (Castro Valley, CA)
Assignee: Gilead Sciences, Inc.
C07D487/04A61K9/0078A61K31/706A61K45/06C07F9/6561C07H7/06C07H19/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,420,972
App. No.
16/879,491
Granted
Aug 23, 2022
Kind
B2
Abstract

Provided are methods for treating Paramyxoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula I: wherein the 1′ position of the nucleoside sugar is substituted. The compounds, compositions, and methods provided are particularly useful for the treatment of Human parainfluenza and Human respiratory syncytial virus infections.

Claims (46)

1. A compound having the structure of Formula III or a pharmaceutically acceptable salt thereof:

wherein

R 2 and R 3 are each OR a ;

R 6 is CN;

R 7 is (C═O)R 11 or

R 8 is NH 2 ;

R 9 is H;

each occurrence of R a is independently H or (C═O)R 11 ;

each occurrence of R 11 is independently H or (C 1 -C 8 )alkyl which is optionally substituted by NH 2 ; and

each occurrence of R is independently H or (C 1 -C 8 )alkyl.

2. The compound of claim 1 , wherein R 7 is

3. The compound of claim 2 , wherein R is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl.

4. The compound of claim 1 , wherein R 2 and R 3 are each OH.

5. The compound of claim 4 , wherein R 7 is —(C═O)—(C 1 -C 8 )alkyl; wherein the (C 1 -C 8 )alkyl of R 7 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

6. The compound of claim 5 , wherein R 7 is —(C═O)—CH(CH 3 ) 2 .

7. The compound of claim 5 , wherein R 7 is —(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

8. The compound of claim 1 , wherein R 2 and R 3 are each —O(C═O)(C 1 -C 8 )alkyl, wherein the (C 1 -C 8 )alkyl groups of R 2 and R 3 are each optionally substituted with NH 2 .

9. The compound of claim 8 , wherein the (C 1 -C 8 )alkyl groups of R 2 and R 3 are each selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted with NH 2 .

10. The compound of claim 9 , wherein each of R 2 and R 3 is selected from the group consisting of —O(C═O)—CH(CH 3 ) 2 and —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

11. The compound of claim 10 , wherein R 2 and R 3 are —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 and —O(C═O)—CH(CH 3 ) 2 , respectively; —O(C═O)—CH(CH 3 ) 2 and —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 , respectively; or —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 and —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 , respectively.

12. The compound of claim 10 , wherein R 2 and R 3 are each —O(C═O)—CH(CH 3 ) 2 .

13. The compound of claim 8 , wherein R 7 is —(C═O)—(C 1 -C 8 )alkyl, wherein the (C 1 -C 8 )alkyl of R 7 is optionally substituted by NH 2 .

14. The compound of claim 13 , wherein the (C 1 -C 8 )alkyl of R 7 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

15. The compound of claim 14 , wherein R 7 is —(C═O)—CH(CH 3 ) 2 .

16. The compound of claim 14 , wherein R 7 is —(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

17. The compound of claim 8 , wherein R 2 is —O(C═O)—CH(CH 3 ) 2 , R 3 is —O(C═O)—CH(CH 3 ) 2 , and R 7 is —(C═O)—CH(CH 3 ) 2 .

18. The compound of claim 1 , wherein R 2 is OH and R 3 is —O(C═O)(C 1 -C 8 )alkyl, wherein the (C 1 -C 8 )alkyl of R 3 is optionally substituted by NH 2 .

19. The compound of claim 18 , wherein the (C 1 -C 8 )alkyl of R 3 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

20. The compound of claim 19 , wherein R 3 is —O(C═O)—CH(CH 3 ) 2 .

21. The compound of claim 19 , wherein R 3 is —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

22. The compound of claim 18 , wherein R 7 is —(C═O)—(C 1 -C 8 )alkyl; wherein the (C 1 -C 8 )alkyl of R 7 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

23. The compound of claim 22 , wherein R 7 is —(C═O)—CH(CH 3 ) 2 .

24. The compound of claim 22 , wherein R 7 is —(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

25. The compound of claim 1 , wherein R 3 is OH and R 2 is —O(C═O)(C 1 -C 8 )alkyl, wherein the (C 1 -C 8 )alkyl of R 2 is optionally substituted by NH 2 .

26. The compound of claim 25 , wherein the (C 1 -C 8 )alkyl of R 2 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, or 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

27. The compound of claim 26 , wherein R 2 is —O(C═O)—CH(CH 3 ) 2 .

28. The compound of claim 26 , wherein R 2 is —O(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

29. The compound of claim 25 , wherein R 7 is —(C═O)—(C 1 -C 8 )alkyl; wherein the (C 1 -C 8 )alkyl of R 7 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl, each of which is optionally substituted by NH 2 .

30. The compound of claim 29 , wherein R 7 is —(C═O)—CH(CH 3 ) 2 .

31. The compound of claim 29 , wherein R 7 is —(C═O)—CH(NH 2 )CH(CH 3 ) 2 .

32. The compound of claim 1 , wherein R 2 and R 3 are each —O(C═O)(C 1 -C 8 )alkyl.

33. The compound of claim 32 , wherein the (C 1 -C 8 )alkyl groups of R 2 and R 3 are each selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl.

34. The compound of claim 32 , wherein R 7 is —(C═O)—(C 1 -C 8 )alkyl.

35. The compound of claim 34 , wherein the (C 1 -C 8 )alkyl of R 7 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl.

36. The compound of claim 4 , wherein R 7 is —(C═O)—(C1-C8)alkyl.

37. The compound of claim 36 , wherein the (C1-C8)alkyl of R 7 is selected from the group consisting of methyl, ethyl, n-propyl, i-propyl, 1-butyl, 2-methyl-1-propyl, 2-butyl, 2-methyl-2-propyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, and 2-methyl-1-butyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2020
From: MACKMAN, RICHARD L.; PARRISH, JAY P.; RAY, ADRIAN S.; THEODORE, DOROTHY ANGES
To: GILEAD SCIENCES, INC.
Reel/Frame 052827/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2020
From: MACKMAN, RICHARD L.; PARRISH, JAY P.; RAY, ADRIAN S.; THEODORE, DOROTHY AGNES
To: GILEAD SCIENCES, INC.
Reel/Frame 052716/0993 →
Continuity (5)
Continuation 16042085 · Jul 23, 2018
Division 14613719 · Feb 4, 2015
Continuation 13189373 · Jul 22, 2011
Provisional Application 61366609 · Jul 22, 2010
Related Publication 20210061806A1 · Mar 4, 2021